Circulating Piwi-Interacting RNAs Associate With Childhood Asthma ICS Response With Vitamin D Effect Modification.

Clin Exp AllergyApr 20, 2026 (epub)

Jiang Li, Xiaoning Hong, Mengshi Chi et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial investigated the association of circulating piwi-interacting RNAs (piRNAs) with inhaled corticosteroid (ICS) response in 492 children with asthma. The study found that 14 piRNAs were significantly linked to changes in FEV1% among vitamin D-insufficient children, with piR-36241 showing strong predictive performance for ICS response (AUROC = 0.84).

Key findings

  • Fourteen piRNAs were significantly associated with FEV1% changes in vitamin D-insufficient children.
  • Six piRNAs showed significant interactions with vitamin D status (p < 0.05).
  • piR-36241 demonstrated strong predictive performance for ICS response (AUROC = 0.84).
  • Four piRNAs were replicated in the GACRS study.

Why it matters

Understanding the role of piRNAs in ICS response could enhance personalized treatment strategies for childhood asthma, particularly for those with vitamin D insufficiency. This may lead to improved management and outcomes in this population.

Source

Published in Clin Exp Allergy. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Allergy & Immunology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.